Content deleted Content added
No edit summary |
No edit summary |
||
Line 64: | Line 64: | ||
[[Category:Cannabinoids]] |
[[Category:Cannabinoids]] |
||
[[Category:Designer drugs]] |
[[Category:Designer drugs]] |
||
[[Category: |
[[Category:Fluoroarenes]] |
||
[[Category:Pyrazoles]] |
[[Category:Pyrazoles]] |
||
[[Category:Pyrazolecarboxamides]] |
[[Category:Pyrazolecarboxamides]] |
Revision as of 19:46, 23 July 2015
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C20H26FN4O2 |
Molar mass | 392,45 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
5F-AB-FUPPYCA (also known as AZ-037) is a pyrazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It was first detected by the EMCDDA as part of a seizure of 540g white powder in France in February 2015.[2]
See also
References
- ^ Ulrich Girreser, Peter Rösner, Andrej Vasilev (May 2015). "Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted 13C NMR shifts – a case study". Drug Testing and Analysis. doi:10.1002/dta.1820. PMID 26012418.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "2015. ÉVI EURÓPAI KÁBÍTÓSZER - JELENTÉS - A MONITOROZÁS 20 ÉVE" (PDF). Hungarian National Focal Point (NFP). June 2015. Retrieved 23 July 2015.